IDMap: facilitating the detection of potential leads with therapeutic targets.

Bioinformatics

BT Solutions Team, R&D Center, Equispharm Co., Ltd, Gyeonggi Bio-Center Bld. 11Fl., 864-1, Iui-dong, Yeongtong-gu, Suwon, Gyeonggi-do 443-766, Republic of Korea.

Published: June 2008

Unlabelled: Pharmaceutical industry has been striving to reduce the costs of drug development and increase productivity. Among the many different attempts, drug repositioning (retargeting existing drugs) comes into the spotlight because of its financial efficiency. We introduce IDMap which predicts novel relationships between targets and chemicals and thus is capable of repositioning the marketed drugs by using text mining and chemical structure information. Also capable of mapping commercial chemicals to possible drug targets and vice versa, IDMap creates convenient environments for identifying the potential lead and its targets, especially in the field of drug repositioning.

Availability: IDMap executable and its user manual including color images are freely available to non-commercial users at http://www.equispharm.com/idmap

Download full-text PDF

Source
http://dx.doi.org/10.1093/bioinformatics/btn138DOI Listing

Publication Analysis

Top Keywords

idmap
4
idmap facilitating
4
facilitating detection
4
detection potential
4
potential leads
4
leads therapeutic
4
targets
4
therapeutic targets
4
targets unlabelled
4
unlabelled pharmaceutical
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!